According to the Research Report, the Size of the Cannabis Testing Market in the Asia Pacific was valued at USD 227 Million in 2020 and estimated to be growing at a CAGR of 11.6%, to reach USD 390.51 million by 2025 during the forecast period 2020 to 2025.
Cannabis is also called as marijuana. There is a risk of accidents when cannabis intoxication is used, which is a drug. This cannabis drug is used for medicinal purposes for relaxation. Awareness is to be increased by conducting seminars, workshops, and conferences. The action of making medical cannabis together with testing laboratories of cannabis has been approved by several nations, which were illegal before. The approval, which is overgrowing for the use of medical marijuana creates demand for analytical equipment for safety testing for the consumption of humans. Ongoing research and development activities are driving the growth of the Asia Pacific (APAC) cannabis testing market.
The high cost of instruments that are relating to or having logical reasoning, the lack of having expert laboratory technicians or the professionals are the factors that restrain the growth of the APAC cannabis testing market. Strict regulations may further control the growth of the APAC cannabis testing market. Lack of standardization that is throughout the industry, is a challenge and may hinder the growth of the APAC Cannabis Testing Market in the coming years.
The increasing government support, along with the mergers and acquisitions by several private companies in the industry, is creating an immense growth potential for the Aisa Pacific cannabis testing market. Also, the rising approvals for the usage in the treatment of a few patients further create development potential for the Cannabis Testing Market in the Asia Pacific.
A macro-level challenge of this advancement, including management risk, improved governance, and the compliance pathology lab to meet the demands of modern pathology may affect regional business growth. Lack of industry standards for cannabis testing and a high start-up cost are the primary challenges in the APAC cannabis testing market. One of the significant challenges faced by the cannabis testing market is having a lack of knowledge and ability or trained professionals who are in the field of testing this drug.
This research report on the APAC Cannabis Testing Market is segmented and sub-segmented into the following categories:
By Testing Procedures:
By End-user:
By Product & Software:
By Country:
The developing economies in Asia-Pacific are the fastest growing regions in the world. Factors like the rising number of road accidents under the influence of cannabis and legalization for medical and recreational purposes in some regions are expected to surge the growth in this region.
Notable companies dominating the APAC Cannabis Testing Market Profiled in the Report Agilent Technologies, Inc., Shimadzu Corporation, Waters Corporation, PerkinElmer, Inc., AB SCIEX LLC, Millipore Sigma, Restek Corporation, LabLynx, Inc. (U.S.), Steep Hill Labs, Inc., PharmLabs, LLC, SC Laboratories, Inc., Digipath Labs, Inc., CannaSafe Analytics, and Accelerated Technology Laboratories, Inc.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product & Software
5.1.1 Analytical Instruments
5.1.1.1 Chromatography Instruments
5.1.1.1.1 Liquid Chromatography
5.1.1.1.2 Gas Chromatography
5.1.1.1.3 Other Chromatography Instruments
5.1.1.2 Spectroscopy Instruments
5.1.1.2.1 Atomic Spectrometry Instruments
5.1.1.2.2 Mass Spectroscopy Instruments
5.1.1.3 Other Analytical Instruments
5.1.2 Consumables
5.1.2.1 Sample Preparation Products
5.1.2.2 Standards and CRMS
5.1.2.3 Chromatography Columns
5.1.2.4 Supplies and Accessories
5.1.3 Software
5.1.5 Y-o-Y Growth Analysis, By Product & Software
5.1.6 Market Attractiveness Analysis, By Product & Software
5.1.7 Market Share Analysis, By Product & Software
5.2 Testing Procedures
5.2.1 Terpene Profiling
5.2.2 Potency Testing
5.2.3 Residual Solvent Screening
5.2.4 Pesticide Screening
5.2.5 Genetic Testing
5.2.6 Heavy Metal Testing
5.2.7 Microbial Analysis
5.2.8 Y-o-Y Growth Analysis, By Testing Procedures
5.2.9 Market Attractiveness Analysis, By Testing Procedures
5.2.10 Market Share Analysis, By Testing Procedures
5.3 End Users
5.3.1 Cannabis Cultivators
5.3.2 Laboratories
5.3.2.1 Small-Scale Laboratories
5.3.2.2 Medium-Scale Laboratories
5.3.2.3 Large-Scale Laboratories
5.3.3 Drug Manufacturers & Dispensaries
5.3.4 Research Institutes
5.3.5 Y-o-Y Growth Analysis, By End Users
5.3.6 Market Attractiveness Analysis, By End Users
5.3.7 Market Share Analysis, By End Users
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Product & Software
6.1.3.2 By Testing Procedures
6.1.3.3 By End Users
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Product & Software
6.1.4.2 By Testing Procedures
6.1.4.3 By End Users
6.1.5 Market Share Analysis
6.1.5.1 By Product & Software
6.1.5.2 By Testing Procedures
6.1.5.3 By End Users
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Agilent Technologies Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Shimadzu Corporation
8.3 Waters Corporation
8.4 PerkinElmer Inc.
8.5 AB SCIEX LLC
8.6 Millipore Sigma
8.7 Restek Corporation
8.8 LabLynx Inc. (U.S.)
8.9 Steep Hill Labs Inc.
8.10 PharmLabs LLC
8.11 SC Laboratories Inc.
8.12 Digipath Labs Inc.
8.13 CannaSafe Analytics
8.14 Accelerated Technology Laboratories Inc.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
